Ashwin K Chetty
he/him/his
About
Research
Publications
Featured Publications
Online Prescribing of GLP-1 Receptor Agonists.
Chetty AK, Chen AS, Ross JS, Ramachandran R. Online Prescribing of GLP-1 Receptor Agonists. JAMA 2026 PMID: 42406378, DOI: 10.1001/jama.2026.9131.Peer-Reviewed Original ResearchOnline Advertising of Compounded Glucagon-Like Peptide-1 Receptor Agonists
Chetty A, Chillakanti M, Ramachandran R, Ross J, Chen A. Online Advertising of Compounded Glucagon-Like Peptide-1 Receptor Agonists. JAMA Health Forum 2025, 6: e245018. PMID: 39820389, PMCID: PMC11742527, DOI: 10.1001/jamahealthforum.2024.5018.Peer-Reviewed Original ResearchClinical Characteristics of Adults at Risk of Medicaid Disenrollment Due to HR 1 Work Requirements
Chetty A, Ross J, Chen A. Clinical Characteristics of Adults at Risk of Medicaid Disenrollment Due to HR 1 Work Requirements. JAMA: The Journal Of The American Medical Association 2025, 334: 1850-1853. PMID: 41032309, PMCID: PMC12489788, DOI: 10.1001/jama.2025.16533.Peer-Reviewed Original ResearchProportion of Obesity-Related Conditions Attributable to Obesity and Overweight in US Youth
Chetty A, Chen A, Hajduk A, Sharifi M, Nugent J. Proportion of Obesity-Related Conditions Attributable to Obesity and Overweight in US Youth. JAMA Pediatrics 2025, 179: 1123-1126. PMID: 40853652, PMCID: PMC12379120, DOI: 10.1001/jamapediatrics.2025.2716.Peer-Reviewed Original ResearchPrevalence of Excess Adiposity by Body Mass Index Category Among US Children and Adolescents
Chetty A, Nugent J, Fenick A, Sharifi M. Prevalence of Excess Adiposity by Body Mass Index Category Among US Children and Adolescents. JAMA Pediatrics 2026, 180: 104-106. PMID: 41182761, PMCID: PMC12584064, DOI: 10.1001/jamapediatrics.2025.4291.Peer-Reviewed Original ResearchPrevalence of excess adiposityCategories of body mass indexExcess adiposityNational Health and Nutrition Examination Survey dataNutrition Examination Survey dataBody mass index categoriesDiagnosis of obesityCross-sectional studyBody mass indexIndex categoriesMass indexPrevalenceSurvey dataAdolescentsObesityAdiposeCategoriesChildrenGlucagon-Like Peptide-1 Receptor Agonist Eligibility Among US Adolescents and Young Adults
Chetty A, Sharifi M, Nugent J. Glucagon-Like Peptide-1 Receptor Agonist Eligibility Among US Adolescents and Young Adults. JAMA Pediatrics 2025, 179: 1119-1121. PMID: 40758363, PMCID: PMC12322816, DOI: 10.1001/jamapediatrics.2025.2308.Peer-Reviewed Original Research
2026
Contribution of Obesity to Polypharmacy in U.S. Older Adults
Chen AS, Chetty AK, Batsis JA, Lipska KJ, Hajduk AM. Contribution of Obesity to Polypharmacy in U.S. Older Adults. Journal Of General Internal Medicine 2026 DOI: 10.1007/s11606-026-10458-8.Peer-Reviewed Original ResearchContribution of Obesity to Polypharmacy in U.S. Older Adults
Chen A, Chetty A, Batsis J, Lipska K, Hajduk A. Contribution of Obesity to Polypharmacy in U.S. Older Adults. Journal Of General Internal Medicine 2026, 1-4. PMID: 42243433, PMCID: PMC13312321, DOI: 10.1007/s11606-026-10458-8.Peer-Reviewed Original ResearchSodium Glucose Cotransporter-2 Inhibitors are Not Associated with Amputation After Lower Extremity Revascularization in Patients with Diabetes
Alappan U, Chetty A, Carter W, Wells N, Alameddine D, Inzucchi S, Guzman R, Ochoa Chaar C. Sodium Glucose Cotransporter-2 Inhibitors are Not Associated with Amputation After Lower Extremity Revascularization in Patients with Diabetes. Annals Of Vascular Surgery 2026, 130: 415-424. PMID: 42162856, DOI: 10.1016/j.avsg.2026.04.067.Peer-Reviewed Original ResearchSodium-glucose cotransporter-2 inhibitorsLower extremity revascularizationPeripheral arterial diseaseCotransporter-2 inhibitorsRetrospective cohort reviewDiabetes mellitusSGLT2i useKaplan-MeierExtremity revascularizationKM analysisReturn to operating roomShorter length of hospital stayLength of hospital stayPostoperative hemoglobin A1cReview of patientsTertiary care centerEndovascular lower extremity revascularizationLong-term outcomesChronic limb-threatening ischemiaAll-cause-mortalityAssociated with amputationAcute limb ischemiaLimb-threatening ischemiaLower-extremity revascularizationCardiorenal benefitsConditions Attributable to Obesity in Older Adults in the U.S.: A Cross-Sectional Study
Chen A, Chetty A, Batsis J, Lipska K, Hajduk A. Conditions Attributable to Obesity in Older Adults in the U.S.: A Cross-Sectional Study. American Journal Of Preventive Medicine 2026, 71: 108419. PMID: 42150623, PMCID: PMC13235660, DOI: 10.1016/j.amepre.2026.108419.Peer-Reviewed Original ResearchPopulation attributable fractionObesity-related conditionsOlder adultsAttributable fractionNational Health and Nutrition Examination SurveyHealth and Nutrition Examination SurveyNutrition Examination SurveyComplex survey methodsA cross-sectional studyCross-sectional studyObesity preventionExamination SurveyObstructive sleep apneaObesity-associated cancersCongestive heart failureChronic kidney diseaseCoronary artery diseasePotential benefitsObesity treatmentObesitySleep apneaAdultsUrinary incontinenceHeart failureArtery disease
News
News
- July 07, 2026
An Online Secret Shopping Study Reveals Easy Access to GLP-1 Prescriptions with Limited Clinician Oversight
- June 22, 2026
Will GLP-1s Lead to Fewer Prescriptions for Older Adults?
- November 11, 2025
New Study Reveals High Disease Burden Among At-Risk Medicaid Beneficiaries
- November 03, 2025
Evaluating the Clinical Necessity of Obtaining Additional Measurements in Children with High BMI